Previous research suggesting loss of smell function may serve as an early marker of Alzheimer's disease has now been supported by a finding that in genetically engineered mice, loss of smell function is associated with amyloid-beta accumulation in the brain, and that amyloid pathology occurs first in the olfactory region. It was striking how sensitive olfactory performance was to even the smallest amount of amyloid presence in the brain as early as three months of age (equivalent to a young adult).
Loss of smell may predict early onset of Alzheimer's
Reference
Wesson, D. W., Levy, E., Nixon, R. A., & Wilson, D. A. (2010). Olfactory Dysfunction Correlates with Amyloid-{beta} Burden in an Alzheimer’s Disease Mouse Model. J. Neurosci., 30(2), 505-514. Retrieved from http://www.jneurosci.org/cgi/content/abstract/30/2/505
Related News
Plaques tell which MCI patients will progress to Alzheimer’s
Submitted by Fiona McPherson
on
A three-year study involving 152 adults aged 50 and older, of whom 52 had been recently diagnosed with mild cognitive impairment and 31 were diagnosed with Alzheimer's disease, has found that those with mild or no cognitive impairment who initially had amyloid-beta plaques showed greater cognitive decline than those whose brain scans were negative for plaques. Moreover, 35% of plaque-positive participants who started with MCI progressed to Alzheimer's, compared to 10% without plaque, and they were more than twice as likely to be started on cognitive-enhancing medication.
Tracking preclinical Alzheimer's progression
Submitted by Fiona McPherson
on
New research supports the classification system for preclinical Alzheimer’s proposed two years ago. The classification system divides preclinical Alzheimer's into three stages:
Stage 1: Levels of amyloid beta begin to decrease in the spinal fluid. This indicates that the substance is beginning to form plaques in the brain.
Stage 2: Levels of tau protein start to increase in the spinal fluid, indicating that brain cells are beginning to die. Amyloid beta levels are still abnormal and may continue to fall.
New biomarker shows Alzheimer's disease long before symptoms
Submitted by Fiona McPherson
on
Analysis of mitochondrial DNA (mtDNA) in the cerebrospinal fluid has found that both symptomatic Alzheimer’s patients and asymptomatic patients at risk of Alzheimer’s showed a significant decrease in levels of circulating cell-free mtDNA in the CSF. Patients with frontotemporal dementia did not display this.
One Alzheimer's risk gene may begin to affect brains from childhood
Submitted by Fiona McPherson
on
A gene linked to Alzheimer's has been linked to brain changes in childhood. This gene, SORL1, has two connections to Alzheimer’s: it carries the code for the sortilin-like receptor, which is involved in recycling some molecules before they develop into amyloid-beta; it is also involved in lipid metabolism, putting it at the heart of the vascular risk pathway.
Long-winded speech could be early sign of Alzheimer's
A study comparing the language abilities of 22 healthy young individuals, 24 healthy older individuals and 22 people with MCI, has found that those with MCI:
Difficulties identifying odors early sign of dementia
A long-term study of nearly 3,000 older adults (57-85) has found that those who couldn’t identify at least four out of five common odors were more than twice as likely as those with a normal sense of smell to develop dementia within five years.
Of the participants, some 14% could name just three out of five, 5% could identify only two scents, 2% just one, and 1% couldn’t identify a single smell.
Navigation difficulties early sign of Alzheimer's
Mobile game detects Alzheimer's risk
A specially designed mobile phone game called Sea Hero Quest has found that gaming data can distinguish between those people who are genetically at risk of developing Alzheimer's disease ond those who are not. The game is designed to test spatial navigation skills — one of the first cognitive areas affected in Alzheimer's.
A standard memory and thinking test could not distinguish between the risk and non-risk groups.
Brain networks disrupted in Alzheimer's disease
Submitted by Fiona McPherson
on
An analysis of the anatomical connectivity in the brains of 15 people with Alzheimer's disease, 68 with mild cognitive impairment and 28 healthy older individuals, has found several measures showed disease effects:
Blood test predicts Alzheimer’s risk early
Submitted by Fiona McPherson
on
A five-year study involving 525 older adults (70+) found 46 had Alzheimer’s or aMCI and a further 28 went on to develop the conditions. The blood levels of 10 specific lipids predicted with more than 90% accuracy whether an individual would go on to develop either Alzheimer’s or aMCI within 2-3 years. The researchers speculate that the lower lipid levels could be an early indication that brain cells are beginning to lose their integrity and break down.
Default mode network changes predict Alzheimer’s
Submitted by Fiona McPherson
on
Data from 848 adults of all ages has found that brain volume in the default mode network declined in both healthy and pathological aging, but the greatest decline occurred in Alzheimer’s patients and in those who progressed from mild cognitive impairment to Alzheimer’s disease. Reduced brain volumes in these regions were associated with declines in cognitive ability, the presence of Alzheimer’s biomarkers in the cerebrospinal fluid, and with carrying the “Alzheimer’s gene”, the APOE4 allele.